Globus Medical Operating Margin 2011-2025 | GMED
Current and historical operating margin for Globus Medical (GMED) over the last 10 years. The current operating profit margin for Globus Medical as of September 30, 2025 is 17.63%.
| Globus Medical Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-09-30 | $2.77B | $0.37B | 13.36% |
| 2025-06-30 | $2.63B | $0.28B | 10.70% |
| 2025-03-31 | $2.51B | $0.26B | 10.16% |
| 2024-12-31 | $2.52B | $0.17B | 6.59% |
| 2024-09-30 | $2.48B | $0.12B | 4.68% |
| 2024-06-30 | $2.24B | $0.07B | 3.04% |
| 2024-03-31 | $1.90B | $0.08B | 4.42% |
| 2023-12-31 | $1.57B | $0.13B | 8.41% |
| 2023-09-30 | $1.23B | $0.18B | 14.34% |
| 2023-06-30 | $1.10B | $0.24B | 21.51% |
| 2023-03-31 | $1.07B | $0.24B | 22.26% |
| 2022-12-31 | $1.02B | $0.23B | 22.29% |
| 2022-09-30 | $1.00B | $0.19B | 19.22% |
| 2022-06-30 | $0.98B | $0.19B | 18.97% |
| 2022-03-31 | $0.96B | $0.16B | 16.94% |
| 2021-12-31 | $0.96B | $0.17B | 17.95% |
| 2021-09-30 | $0.94B | $0.21B | 22.64% |
| 2021-06-30 | $0.93B | $0.21B | 22.65% |
| 2021-03-31 | $0.83B | $0.14B | 16.73% |
| 2020-12-31 | $0.79B | $0.11B | 14.07% |
| 2020-09-30 | $0.77B | $0.10B | 13.28% |
| 2020-06-30 | $0.75B | $0.09B | 12.57% |
| 2020-03-31 | $0.79B | $0.16B | 20.53% |
| 2019-12-31 | $0.79B | $0.17B | 21.88% |
| 2019-09-30 | $0.77B | $0.17B | 21.43% |
| 2019-06-30 | $0.74B | $0.16B | 21.67% |
| 2019-03-31 | $0.72B | $0.16B | 22.19% |
| 2018-12-31 | $0.71B | $0.17B | 23.74% |
| 2018-09-30 | $0.69B | $0.17B | 25.14% |
| 2018-06-30 | $0.68B | $0.17B | 25.48% |
| 2018-03-31 | $0.65B | $0.17B | 25.54% |
| 2017-12-31 | $0.64B | $0.16B | 25.31% |
| 2017-09-30 | $0.61B | $0.15B | 24.35% |
| 2017-06-30 | $0.60B | $0.15B | 25.34% |
| 2017-03-31 | $0.58B | $0.15B | 26.16% |
| 2016-12-31 | $0.56B | $0.16B | 27.48% |
| 2016-09-30 | $0.56B | $0.18B | 31.53% |
| 2016-06-30 | $0.56B | $0.18B | 32.01% |
| 2016-03-31 | $0.55B | $0.18B | 32.01% |
| 2015-12-31 | $0.55B | $0.17B | 31.68% |
| 2015-09-30 | $0.53B | $0.16B | 29.51% |
| 2015-06-30 | $0.51B | $0.15B | 29.43% |
| 2015-03-31 | $0.49B | $0.15B | 29.61% |
| 2014-12-31 | $0.48B | $0.14B | 29.26% |
| 2014-09-30 | $0.46B | $0.13B | 28.42% |
| 2014-06-30 | $0.45B | $0.13B | 28.00% |
| 2014-03-31 | $0.44B | $0.11B | 23.70% |
| 2013-12-31 | $0.43B | $0.10B | 23.50% |
| 2013-09-30 | $0.42B | $0.10B | 23.57% |
| 2013-06-30 | $0.41B | $0.10B | 23.53% |
| 2013-03-31 | $0.40B | $0.12B | 29.22% |
| 2012-12-31 | $0.39B | $0.12B | 29.72% |
| 2012-09-30 | $0.37B | $0.11B | 29.41% |
| 2012-06-30 | $0.36B | $0.11B | 30.30% |
| 2012-03-31 | $0.35B | $0.10B | 29.60% |
| 2011-12-31 | $0.33B | $0.10B | 29.61% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $11.330B | $2.519B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.059B | 25.55 |
| Intuitive Surgical (ISRG) | United States | $200.747B | 78.54 |
| IDEXX Laboratories (IDXX) | United States | $56.571B | 56.18 |
| Edwards Lifesciences (EW) | United States | $48.391B | 32.45 |
| Alcon (ALC) | Switzerland | $36.485B | 24.49 |
| IQVIA Holdings (IQV) | United States | $35.841B | 19.99 |
| Mettler-Toledo (MTD) | United States | $29.649B | 34.40 |
| STERIS (STE) | Ireland | $25.888B | 26.72 |
| Waters (WAT) | United States | $22.128B | 29.27 |
| DexCom (DXCM) | United States | $21.451B | 29.57 |
| Hologic (HOLX) | United States | $16.481B | 17.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.721B | 0.00 |
| Penumbra (PEN) | United States | $10.425B | 73.33 |
| Masimo (MASI) | United States | $7.690B | 24.64 |
| Sysmex ADR (SSMXY) | Japan | $6.698B | 21.28 |
| Teleflex (TFX) | United States | $4.835B | 7.70 |
| Glaukos (GKOS) | United States | $4.816B | 0.00 |
| TransMedics (TMDX) | United States | $4.073B | 48.25 |
| Veracyte (VCYT) | United States | $3.296B | 37.57 |
| Alphatec Holdings (ATEC) | United States | $2.941B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.755B | 14.88 |
| Integer Holdings (ITGR) | United States | $2.392B | 11.23 |
| Artivion (AORT) | United States | $2.117B | 97.54 |
| Nihon Kohden (NHNKY) | Japan | $2.067B | 24.67 |
| PROCEPT BioRobotics (PRCT) | United States | $1.784B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.686B | 16.34 |
| Beta Bionics (BBNX) | United States | $1.158B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.099B | 0.00 |
| AxoGen (AXGN) | United States | $1.087B | 0.00 |
| IRadimed (IRMD) | United States | $1.073B | 51.11 |
| Pulse Biosciences (PLSE) | United States | $1.048B | 0.00 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.938B | 5.08 |
| SiBone (SIBN) | United States | $0.680B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.591B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.555B | 32.29 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.521B | 10.40 |
| AngioDynamics (ANGO) | United States | $0.495B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.449B | 0.00 |
| NeuroPace (NPCE) | United States | $0.437B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.427B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.418B | 11.59 |
| Semler Scientific (SMLR) | United States | $0.418B | 3.28 |
| RxSight (RXST) | United States | $0.385B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.327B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.305B | 50.82 |
| Sight Sciences (SGHT) | United States | $0.305B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.294B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.265B | 0.00 |
| CVRx (CVRX) | United States | $0.255B | 0.00 |
| Inogen (INGN) | United States | $0.189B | 0.00 |
| Neuronetics (STIM) | United States | $0.156B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.144B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| LENSAR (LNSR) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.084B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.077B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.060B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.038B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Envoy Medical (COCH) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.54 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |